Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 38% ± 13% | |
brain | 19 studies | 40% ± 20% | |
peripheral blood | 17 studies | 29% ± 11% | |
eye | 11 studies | 31% ± 13% | |
intestine | 10 studies | 29% ± 14% | |
kidney | 9 studies | 30% ± 5% | |
liver | 6 studies | 33% ± 13% | |
heart | 5 studies | 30% ± 3% | |
prostate | 5 studies | 26% ± 10% | |
lymph node | 5 studies | 30% ± 11% | |
breast | 5 studies | 31% ± 6% | |
pancreas | 4 studies | 66% ± 17% | |
placenta | 4 studies | 50% ± 17% | |
bone marrow | 4 studies | 32% ± 16% | |
uterus | 4 studies | 44% ± 15% | |
adipose | 4 studies | 41% ± 16% | |
esophagus | 3 studies | 46% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 6872.66 | 258 / 258 | 100% | 98.28 | 230 / 230 |
breast | 100% | 8391.27 | 459 / 459 | 100% | 135.68 | 1118 / 1118 |
esophagus | 100% | 7626.42 | 1445 / 1445 | 100% | 84.59 | 183 / 183 |
intestine | 100% | 6314.96 | 966 / 966 | 100% | 93.16 | 527 / 527 |
liver | 100% | 5075.16 | 226 / 226 | 100% | 69.04 | 406 / 406 |
ovary | 100% | 5026.25 | 180 / 180 | 100% | 89.31 | 430 / 430 |
prostate | 100% | 6392.06 | 245 / 245 | 100% | 114.57 | 502 / 502 |
stomach | 100% | 4935.72 | 359 / 359 | 100% | 91.29 | 286 / 286 |
thymus | 100% | 7037.15 | 653 / 653 | 100% | 96.36 | 605 / 605 |
uterus | 100% | 6372.67 | 170 / 170 | 100% | 84.34 | 459 / 459 |
brain | 100% | 8128.62 | 2640 / 2642 | 100% | 123.97 | 705 / 705 |
lung | 100% | 6403.63 | 577 / 578 | 100% | 92.23 | 1155 / 1155 |
bladder | 100% | 6372.57 | 21 / 21 | 100% | 90.53 | 503 / 504 |
kidney | 100% | 5446.29 | 89 / 89 | 100% | 75.17 | 897 / 901 |
skin | 100% | 7432.47 | 1808 / 1809 | 99% | 78.38 | 467 / 472 |
pancreas | 99% | 3514.74 | 326 / 328 | 99% | 85.45 | 177 / 178 |
adipose | 100% | 9736.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9496.59 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 36.58 | 29 / 29 |
muscle | 100% | 9419.94 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4050.88 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 66.54 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 45.57 | 1 / 1 |
heart | 98% | 5589.32 | 845 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 81.47 | 75 / 80 |
peripheral blood | 83% | 2858.96 | 773 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016236 | Biological process | macroautophagy |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0007030 | Biological process | Golgi organization |
GO_0015031 | Biological process | protein transport |
GO_0006888 | Biological process | endoplasmic reticulum to Golgi vesicle-mediated transport |
GO_0001669 | Cellular component | acrosomal vesicle |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0033116 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005829 | Cellular component | cytosol |
GO_0042470 | Cellular component | melanosome |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005634 | Cellular component | nucleus |
GO_0019003 | Molecular function | GDP binding |
GO_0005525 | Molecular function | GTP binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RAB2A |
Protein name | small monomeric GTPase (EC 3.6.5.2) RAB2A, member RAS oncogene family Ras-related protein Rab-2A (EC 3.6.5.2) |
Synonyms | RAB2 |
Description | FUNCTION: The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between active GTP-bound and inactive GDP-bound states. In their active state, drive transport of vesicular carriers from donor organelles to acceptor organelles to regulate the membrane traffic that maintains organelle identity and morphology. Required for protein transport from the endoplasmic reticulum to the Golgi complex. Regulates the compacted morphology of the Golgi. . FUNCTION: The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between active GTP-bound and inactive GDP-bound states. In their active state, drive transport of vesicular carriers from donor organelles to acceptor organelles to regulate the membrane traffic that maintains organelle identity and morphology. Required for protein transport from the endoplasmic reticulum to the Golgi complex. Regulates the compacted morphology of the Golgi. . FUNCTION: The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between active GTP-bound and inactive GDP-bound states. In their active state, drive transport of vesicular carriers from donor organelles to acceptor organelles to regulate the membrane traffic that maintains organelle identity and morphology. Required for protein transport from the endoplasmic reticulum to the Golgi complex. Regulates the compacted morphology of the Golgi. . |
Accessions | ENST00000529579.5 A0A1D5RMT4 ENST00000531098.1 P61019 H7C125 ENST00000452437.1 E9PKL7 ENST00000466595.5 ENST00000262646.12 [P61019-1] ENST00000531289.5 [P61019-2] ENST00000534260.5 H0YDL5 H0YD31 |